| Autor: |
Geat, Davide, Gisondi, Paolo, Maurelli, Martina, Puig, Luis, Paul, Carle, Thaçi, Diamant, Iversen, Lars, Bellinato, Francesco, Girolomoni, Giampiero |
| Předmět: |
|
| Zdroj: |
Journal of the European Academy of Dermatology & Venereology; Aug2024, Vol. 38 Issue 8, pe663-e665, 3p |
| Abstrakt: |
This article discusses the price variability of TNF-α inhibitor biosimilars for the treatment of psoriasis across European countries. The study found that there is significant price variability, with lower prices in Italy and Spain compared to Germany, France, and Denmark. The pricing policies adopted by different countries, such as mandatory discounts, progressive price discounts, and tendering or direct contracting, contribute to this variability. The findings highlight the potential impact on healthcare costs and patient access to biological treatment. However, it is important to note that the study only included one center per country. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text